Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV003231511 | SCV000596111 | likely pathogenic | Sotos syndrome | 2017-01-19 | criteria provided, single submitter | clinical testing | |
Equipe Genetique des Anomalies du Developpement, |
RCV003231511 | SCV000803850 | likely pathogenic | Sotos syndrome | 2016-08-03 | criteria provided, single submitter | clinical testing | |
Equipe Genetique des Anomalies du Developpement, |
RCV000850418 | SCV000992616 | likely pathogenic | Marfanoid habitus and intellectual disability | criteria provided, single submitter | research | ||
Labcorp Genetics |
RCV005056091 | SCV002963507 | pathogenic | not provided | 2022-07-10 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 2007 of the NSD1 protein (p.Ile2007Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of Sotos syndrome (PMID: 32277047). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 436065). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NSD1 protein function. |